EP
AGN

Elkfork Partners’s Allergan plc AGN Stock Holding History

Elkfork Partners’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$1.58M Sell
9,416
-35,046
-79% -$5.71M 0.04% 307
2019
Q2 		$7.44M Sell
44,462
-16,412
-27% -$2.27M 0.18% 112
2019
Q1 		$8.91M Buy
60,874
+22,836
+60% +$3.31M 0.22% 94
2018
Q4 		$5.08M Buy
38,038
+21,120
+125% +$3.46M 0.14% 148
2018
Q3 		$3.22M Sell
16,918
-3,894
-19% -$715K 0.08% 219
2018
Q2 		$3.47M Buy
20,812
+5,302
+34% +$851K 0.09% 200
2018
Q1 		$2.61M Buy
15,510
+8,338
+116% +$1.4M 0.07% 211
2017
Q4 		$1.17M Buy
7,172
+1,408
+24% +$253K 0.03% 329
2017
Q3 		$1.18M Buy
5,764
+22
+0.4% +$5.12K 0.03% 304
2017
Q2 		$1.4M Sell
5,742
-36,982
-87% -$8.69M 0.04% 282
2017
Q1 		$10.2M Sell
42,724
-1,936
-4% -$451K 0.31% 65
2016
Q4 		$9.38M Buy
+44,660
New +$9.25M 0.31% 62

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
LP
Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Elkfork Partners's AGN Position: Q3 2019 in Review

Elkfork Partners reduced its Allergan plc (AGN) stake by 79% in Q3 2019, selling an estimated $5.71M and leaving 9,416 shares worth $1.58M. The position accounts for 0.04% of the portfolio, ranked #307.

Elkfork Partners first reported a position in AGN in Q4 2016 and has held it in 12 quarters since. The position peaked at $10.2M in Q1 2017. 921 funds tracked by Wall St. Rank hold AGN as of Q3 2019.

  • Elkfork Partners held 9,416 shares of Allergan plc worth $1.58M as of Q3 2019.
  • Elkfork Partners sold 35,046 Allergan plc shares in Q3 2019, an estimated $5.71M.
  • Allergan plc made up 0.04% of Elkfork Partners's portfolio in Q3 2019, its #307 holding.
  • Elkfork Partners first reported a position in Allergan plc in Q4 2016 and has held it in 12 quarters since.
  • Elkfork Partners's Allergan plc position peaked at $10.2M in Q1 2017.
  • 921 funds tracked by Wall St. Rank held Allergan plc as of Q3 2019.

Based on Elkfork Partners's 13F filing for Q3 2019, filed 14 Nov 2019.